XML 17 R2.htm IDEA: XBRL DOCUMENT
v3.25.1

Pay vs Performance Disclosure | 3 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | ---
Apr. 10, 2022 | Dec. 31, 2022 | Dec. 31, 2024 USD ($) $ / shares | Dec. 31, 2023 USD ($) $ / shares | Dec. 31, 2022 USD ($) $ / shares | Dec. 31, 2021 USD ($) $ / shares | Dec. 31, 2020 USD ($) $ / shares
Pay vs Performance Disclosure |  |  |  |  |  |  |
Pay vs Performance Disclosure, Table |  |  | Pay Versus Performance The following table sets forth certain information regarding compensation actually paid to our Named Executive Officers during the past five fiscal years compared to certain measures of our financial performance:
| Summary Comp. Table Total for CEO |  | Comp. Actually Paid to CEO(3) |  |  | Average Summary Comp. Table Total for Non-CEO NEOs(4) |  |  | Average Comp. Actually Paid to Non-CEO NEOs(3) |  |  | Value of Initial Fixed $100 Investment Based On: |  |  | Net Income (Loss) (in thousands) |  |  | Adjusted EPS(7) |
Year | Christopher H. Hunter(1) |  |  | Debra K. Osteen(2) |  | Christopher H. Hunter(1) |  | Debra K. Osteen(2) |  |  |  |  |  |  | TSR(5) |  |  | Peer Group TSR(6) |  |  |  |  |
2024 |  |  | $ | 7,089,167 |  |  | $ | N/A |  |  | $ | (241,669 | ) |  | $ | N/A |  |  | $ | 2,238,478 |  |  | $ | (19,323 | ) |  | $ | 119 |  |  | $ | 126 |  |  | $ | 264,484 |  |  | $ | 3.32 |
2023 |  |  |  | 7,404,606 |  |  |  | N/A |  |  |  | 8,352,752 |  |  |  | N/A |  |  |  | 3,289,184 |  |  |  | 1,079,088 |  |  |  | 234 |  |  |  | 124 |  |  |  | (15,661 | ) |  |  | 3.51 |
2022 |  |  |  | 6,415,224 |  |  |  | 2,620,043 |  |  |  | 8,482,132 |  |  |  | 17,102,308 |  |  |  | 3,040,751 |  |  |  | 9,817,787 |  |  |  | 248 |  |  |  | 118 |  |  |  | 280,033 |  |  |  | 3.19 |
2021 |  |  |  | N/A |  |  |  | 9,853,107 |  |  |  | N/A |  |  |  | 29,812,731 |  |  |  | 3,656,112 |  |  |  | 8,870,858 |  |  |  | 183 |  |  |  | 147 |  |  |  | 195,562 |  |  |  | 2.70 |
2020 |  |  |  | N/A |  |  |  | 5,131,395 |  |  |  | N/A |  |  |  | 17,648,915 |  |  |  | 2,604,425 |  |  |  | 6,550,425 |  |  |  | 151 |  |  |  | 134 |  |  |  | (669,199 | ) |  |  | 2.81 |
| (1) | Mr. Hunter was appointed Chief Executive Officer effective April 11, 2022.
| (2) | Ms. Osteen retired as Chief Executive Officer effective April 11, 2022.
| (3) | To calculate Compensation Actually Paid (“CAP”), the following amounts were deducted from and added to Summary Compensation Table (“SCT”) total compensation:
CEO SCT Table to CAP Reconciliation:
Name |  |  | Year |  |  | SCT Total |  |  | Deductions from SCT Total(a) |  |  | Additions to SCT Total(b) |  |  | CAP |
Christopher H. Hunter |  |  | 2024 |  |  | $ | 7,089,167 |  |  | $ | 5,099,925 |  |  | $ | (2,230,911 | ) |  | $ | (241,669 | )
|  |  | 2023 |  |  |  | 7,404,606 |  |  |  | 4,749,977 |  |  |  | 5,698,123 |  |  |  | 8,352,752 |
|  |  | 2022 |  |  |  | 6,415,224 |  |  |  | 4,500,022 |  |  |  | 6,566,930 |  |  |  | 8,482,132 |
Debra K. Osteen |  |  | 2024 |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
|  |  | 2023 |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
|  |  | 2022 |  |  |  | 2,620,043 |  |  |  | 1,059,857 |  |  |  | 15,542,122 |  |  |  | 17,102,308 |
|  |  | 2021 |  |  |  | 9,853,107 |  |  |  | 6,989,753 |  |  |  | 26,949,377 |  |  |  | 29,812,731 |
|  |  | 2020 |  |  |  | 5,131,395 |  |  |  | 2,789,779 |  |  |  | 15,307,298 |  |  |  | 17,648,915 |
Average Non-CEO NEOs SCT Table to CAP Reconciliation:
|  |  | Year |  |  | SCT Total |  |  | Deductions from SCT Total(a) |  |  | Additions to SCT Total(b) |  |  | CAP |
|  |  | 2024 |  |  | $ | 2,238,478 |  |  | $ | 1,179,647 |  |  | $ | (1,078,154 | ) |  | $ | (19,323 | )
|  |  | 2023 |  |  |  | 3,289,184 |  |  |  | 2,503,492 |  |  |  | 293,396 |  |  |  | 1,079,088 |
|  |  | 2022 |  |  |  | 3,040,751 |  |  |  | 1,720,243 |  |  |  | 8,497,279 |  |  |  | 9,817,787 |
|  |  | 2021 |  |  |  | 3,656,112 |  |  |  | 1,963,594 |  |  |  | 7,178,340 |  |  |  | 8,870,858 |
|  |  | 2020 |  |  |  | 2,604,425 |  |  |  | 1,116,717 |  |  |  | 5,062,717 |  |  |  | 6,550,425 |
| (a) | Represents the grant date fair value of equity-based awards granted each year calculated in accordance with ASC 718.
| (b) | Reflects the value of equity calculated in accordance with the SEC methodology for determining CAP for each year shown. The equity component of CAP is further detailed in the table below. For performance-vesting restricted stock unit awards, fair value amounts have been computed consistent with the methodology used in the Company’s Consolidated Financial Statements as of December 31, 2020, 2021, 2022, 2023 and 2024, respectively.
Equity Component of CAP: Christopher H. Hunter
Year |  |  | Fair Value of Current Year Equity Awards at Year-End |  |  | Change in Value of Prior Years’ Awards Unvested at Year-End |  |  | Change in Value of Prior Years’ Awards That Vested in the Year |  |  | Equity Value Included in CAP |
2024 |  |  | $ | 2,975,019 |  |  | $ | (5,148,737 | ) |  |  | (57,192 | ) |  | $ | (2,230,911 | )
2023 |  |  |  | 6,050,233 |  |  |  | (321,521 | ) |  |  | (30,589 | ) |  |  | 5,698,123 |
2022 |  |  |  | 6,566,930 |  |  |  | – |  |  |  | – |  |  |  | 6,566,930 |
2021 |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
2020 |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
Debra K. Osteen
Year |  |  | Fair Value of Current Year Equity Awards at Year-End |  |  | Change in Value of Prior Years’ Awards Unvested at Year-End |  |  | Change in Value of Prior Years’ Awards That Vested in the Year |  |  | Equity Value Included in CAP |
2024 |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
2023 |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
2022 |  |  | $ | 9,972,986 |  |  | $ | 7,341,244 |  |  | $ | (1,772,108 | ) |  | $ | 15,542,122 |
2021 |  |  |  | 23,567,139 |  |  |  | 3,215,353 |  |  |  | 166,885 |  |  |  | 26,949,377 |
2020 |  |  |  | 13,014,224 |  |  |  | 533,148 |  |  |  | 1,759,927 |  |  |  | 15,307,298 |
Average Non-CEO NEOs
Year |  |  | Fair Value of Current Year Equity Awards at Year-End |  |  | Change in Value of Prior Years’ Awards Unvested at Year-End |  |  | Change in Value of Prior Years’ Awards That Vested in the Year |  |  | Fair Value of Forfeited Awards at Prior Year-End |  |  | Equity Value Included in CAP |
2024 |  |  | $ | 679,492 |  |  | $ | (1,278,180 | ) |  | $ | (19,593 | ) |  | $ | (459,873 | ) |  | $ | (1,078,154 | )
2023 |  |  |  | 2,182,972 |  |  |  | (89,974 | ) |  |  | (255,921 | ) |  |  | (1,543,681 | ) |  |  | 293,396 |
2022 |  |  |  | 5,228,345 |  |  |  | 3,399,089 |  |  |  | (130,155 | ) |  |  | – |  |  |  | 8,497,279 |
2021 |  |  |  | 5,891,861 |  |  |  | 1,147,507 |  |  |  | 138,972 |  |  |  | – |  |  |  | 7,178,340 |
2020 |  |  |  | 4,691,771 |  |  |  | 419,942 |  |  |  | (48,996 | ) |  |  | – |  |  |  | 5,062,717 |
| (4) | The Named Executive Officers, other than the CEO, reflected in the Pay Versus Performance table represent the following individuals for each of the years listed below
2020 | 2021 | 2022 | 2023 | 2024
David M. Duckworth | David M. Duckworth | David M. Duckworth | Heather Dixon | Heather Dixon
Christopher L. Howard | Christopher L. Howard | Christopher L. Howard | Brian P. Farley | Brian P. Farley
John S. Hollinsworth | John S. Hollinsworth | John S. Hollinsworth | John S. Hollinsworth | Nasser Khan, M.D.
Laurence L. Harrod | Laurence L. Harrod | Laurence L. Harrod | David M. Duckworth | John S. Hollinsworth
|  |  | Laurence L. Harrod |
| (5) | An investment of $100 is assumed to have been made in our Common Stock as of December 31, 2019. TSR was calculated by multiplying the initial investment of $100 by the quotient of the closing price of our Common Stock on December 31, 2020, 2021, 2022, 2023 and 2024, divided by our closing price on December 31, 2019.
| (6) | Reflects the cumulative total stockholder return for the S&P Health Care Services Select Industry Index (the “S&P HC Index”). An investment of $100 is assumed to have been made in the S&P HC Index as of December 31, 2019. Peer Group TSR was calculated by multiplying the initial investment of $100 by the quotient of the closing price of the S&P HC Index on December 31, 2020, 2021, 2022, 2023 and 2024 divided by the closing price on December 31, 2019, with dividends reinvested at the time they are paid.
| (7) | Adjusted EPS is a non-GAAP financial measure and one of the core long-term metrics we use for purposes of evaluating performance for our compensation program, as further described in the section above entitled “COMPENSATION DISCUSSION AND ANALYSIS – Components of Executive Compensation – Annual Non-Equity Incentive Compensation.”
Company Selected Measure Name |  |  | Adjusted EPS |  |  |  |
Named Executive Officers, Footnote |  |  |
| (1) | Mr. Hunter was appointed Chief Executive Officer effective April 11, 2022.
| (2) | Ms. Osteen retired as Chief Executive Officer effective April 11, 2022.
| (4) | The Named Executive Officers, other than the CEO, reflected in the Pay Versus Performance table represent the following individuals for each of the years listed below
2020 | 2021 | 2022 | 2023 | 2024
David M. Duckworth | David M. Duckworth | David M. Duckworth | Heather Dixon | Heather Dixon
Christopher L. Howard | Christopher L. Howard | Christopher L. Howard | Brian P. Farley | Brian P. Farley
John S. Hollinsworth | John S. Hollinsworth | John S. Hollinsworth | John S. Hollinsworth | Nasser Khan, M.D.
Laurence L. Harrod | Laurence L. Harrod | Laurence L. Harrod | David M. Duckworth | John S. Hollinsworth
|  |  | Laurence L. Harrod |
Peer Group Issuers, Footnote |  |  |
| (6) | Reflects the cumulative total stockholder return for the S&P Health Care Services Select Industry Index (the “S&P HC Index”). An investment of $100 is assumed to have been made in the S&P HC Index as of December 31, 2019. Peer Group TSR was calculated by multiplying the initial investment of $100 by the quotient of the closing price of the S&P HC Index on December 31, 2020, 2021, 2022, 2023 and 2024 divided by the closing price on December 31, 2019, with dividends reinvested at the time they are paid.
Adjustment To PEO Compensation, Footnote |  |  |
| (3) | To calculate Compensation Actually Paid (“CAP”), the following amounts were deducted from and added to Summary Compensation Table (“SCT”) total compensation:
CEO SCT Table to CAP Reconciliation:
Name |  |  | Year |  |  | SCT Total |  |  | Deductions from SCT Total(a) |  |  | Additions to SCT Total(b) |  |  | CAP |
Christopher H. Hunter |  |  | 2024 |  |  | $ | 7,089,167 |  |  | $ | 5,099,925 |  |  | $ | (2,230,911 | ) |  | $ | (241,669 | )
|  |  | 2023 |  |  |  | 7,404,606 |  |  |  | 4,749,977 |  |  |  | 5,698,123 |  |  |  | 8,352,752 |
|  |  | 2022 |  |  |  | 6,415,224 |  |  |  | 4,500,022 |  |  |  | 6,566,930 |  |  |  | 8,482,132 |
Debra K. Osteen |  |  | 2024 |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
|  |  | 2023 |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
|  |  | 2022 |  |  |  | 2,620,043 |  |  |  | 1,059,857 |  |  |  | 15,542,122 |  |  |  | 17,102,308 |
|  |  | 2021 |  |  |  | 9,853,107 |  |  |  | 6,989,753 |  |  |  | 26,949,377 |  |  |  | 29,812,731 |
|  |  | 2020 |  |  |  | 5,131,395 |  |  |  | 2,789,779 |  |  |  | 15,307,298 |  |  |  | 17,648,915 |
| (a) | Represents the grant date fair value of equity-based awards granted each year calculated in accordance with ASC 718.
| (b) | Reflects the value of equity calculated in accordance with the SEC methodology for determining CAP for each year shown. The equity component of CAP is further detailed in the table below. For performance-vesting restricted stock unit awards, fair value amounts have been computed consistent with the methodology used in the Company’s Consolidated Financial Statements as of December 31, 2020, 2021, 2022, 2023 and 2024, respectively.
Equity Component of CAP: Christopher H. Hunter
Year |  |  | Fair Value of Current Year Equity Awards at Year-End |  |  | Change in Value of Prior Years’ Awards Unvested at Year-End |  |  | Change in Value of Prior Years’ Awards That Vested in the Year |  |  | Equity Value Included in CAP |
2024 |  |  | $ | 2,975,019 |  |  | $ | (5,148,737 | ) |  |  | (57,192 | ) |  | $ | (2,230,911 | )
2023 |  |  |  | 6,050,233 |  |  |  | (321,521 | ) |  |  | (30,589 | ) |  |  | 5,698,123 |
2022 |  |  |  | 6,566,930 |  |  |  | – |  |  |  | – |  |  |  | 6,566,930 |
2021 |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
2020 |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
Debra K. Osteen
Year |  |  | Fair Value of Current Year Equity Awards at Year-End |  |  | Change in Value of Prior Years’ Awards Unvested at Year-End |  |  | Change in Value of Prior Years’ Awards That Vested in the Year |  |  | Equity Value Included in CAP |
2024 |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
2023 |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
2022 |  |  | $ | 9,972,986 |  |  | $ | 7,341,244 |  |  | $ | (1,772,108 | ) |  | $ | 15,542,122 |
2021 |  |  |  | 23,567,139 |  |  |  | 3,215,353 |  |  |  | 166,885 |  |  |  | 26,949,377 |
2020 |  |  |  | 13,014,224 |  |  |  | 533,148 |  |  |  | 1,759,927 |  |  |  | 15,307,298 |
Non-PEO NEO Average Total Compensation Amount |  |  | $ 2,238,478 | $ 3,289,184 | $ 3,040,751 | $ 3,656,112 | $ 2,604,425
Non-PEO NEO Average Compensation Actually Paid Amount |  |  | $ (19,323) | 1,079,088 | 9,817,787 | 8,870,858 | 6,550,425
Adjustment to Non-PEO NEO Compensation Footnote |  |  |
| (3) | To calculate Compensation Actually Paid (“CAP”), the following amounts were deducted from and added to Summary Compensation Table (“SCT”) total compensation:
Average Non-CEO NEOs SCT Table to CAP Reconciliation:
|  |  | Year |  |  | SCT Total |  |  | Deductions from SCT Total(a) |  |  | Additions to SCT Total(b) |  |  | CAP |
|  |  | 2024 |  |  | $ | 2,238,478 |  |  | $ | 1,179,647 |  |  | $ | (1,078,154 | ) |  | $ | (19,323 | )
|  |  | 2023 |  |  |  | 3,289,184 |  |  |  | 2,503,492 |  |  |  | 293,396 |  |  |  | 1,079,088 |
|  |  | 2022 |  |  |  | 3,040,751 |  |  |  | 1,720,243 |  |  |  | 8,497,279 |  |  |  | 9,817,787 |
|  |  | 2021 |  |  |  | 3,656,112 |  |  |  | 1,963,594 |  |  |  | 7,178,340 |  |  |  | 8,870,858 |
|  |  | 2020 |  |  |  | 2,604,425 |  |  |  | 1,116,717 |  |  |  | 5,062,717 |  |  |  | 6,550,425 |
| (a) | Represents the grant date fair value of equity-based awards granted each year calculated in accordance with ASC 718.
| (b) | Reflects the value of equity calculated in accordance with the SEC methodology for determining CAP for each year shown. The equity component of CAP is further detailed in the table below. For performance-vesting restricted stock unit awards, fair value amounts have been computed consistent with the methodology used in the Company’s Consolidated Financial Statements as of December 31, 2020, 2021, 2022, 2023 and 2024, respectively.
Equity Component of CAP: Average Non-CEO NEOs
Year |  |  | Fair Value of Current Year Equity Awards at Year-End |  |  | Change in Value of Prior Years’ Awards Unvested at Year-End |  |  | Change in Value of Prior Years’ Awards That Vested in the Year |  |  | Fair Value of Forfeited Awards at Prior Year-End |  |  | Equity Value Included in CAP |
2024 |  |  | $ | 679,492 |  |  | $ | (1,278,180 | ) |  | $ | (19,593 | ) |  | $ | (459,873 | ) |  | $ | (1,078,154 | )
2023 |  |  |  | 2,182,972 |  |  |  | (89,974 | ) |  |  | (255,921 | ) |  |  | (1,543,681 | ) |  |  | 293,396 |
2022 |  |  |  | 5,228,345 |  |  |  | 3,399,089 |  |  |  | (130,155 | ) |  |  | – |  |  |  | 8,497,279 |
2021 |  |  |  | 5,891,861 |  |  |  | 1,147,507 |  |  |  | 138,972 |  |  |  | – |  |  |  | 7,178,340 |
2020 |  |  |  | 4,691,771 |  |  |  | 419,942 |  |  |  | (48,996 | ) |  |  | – |  |  |  | 5,062,717 |
Compensation Actually Paid vs. Total Shareholder Return |  |  | Comparison of Compensation Actually Paid and Company TSR The following graph reflects the relationship between our CEO and average non-CEO NEO “compensation actually paid” versus our cumulative TSR, assuming an initial fixed investment of $100 on December 31, 2019, for the years ended December 31, 2020, 2021, 2022, 2023 and 2024. |  |  |  |
Compensation Actually Paid vs. Net Income |  |  | Comparison of Compensation Actually Paid and Net Income The following graph reflects the relationship between our CEO and average non-CEO NEO “compensation actually paid” and our net income for the years ended December 31, 2020, 2021, 2022, 2023 and 2024. |  |  |  |
Compensation Actually Paid vs. Company Selected Measure |  |  | Comparison of Compensation Actually Paid and Adjusted EPS The following graph reflects the relationship between our CEO and average non-CEO NEO “compensation actually paid” and our Adjusted EPS for the years ended December 31, 2020, 2021, 2022, 2023 and 2024. |  |  |  |
Total Shareholder Return Vs Peer Group |  |  | Comparison of Company TSR and Peer Group TSR The following graph reflects the relationship between our TSR and the TSR of the peer group presented for this purpose, the S&P HC Index. |  |  |  |
Tabular List, Table |  |  | Financial Performance Measures As further described in the section above entitled “COMPENSATION DISCUSSION AND ANALYSIS – Components of Executive Compensation,” the Company’s executive compensation program is heavily weighted to performance-based pay, with a significant emphasis on long-term performance and stockholder value creation. The Company primarily uses three core metrics across its long-term and short-term incentive awards: Adjusted EPS, Adjusted EBITDA and revenue. The Company uses Adjusted EPS, Adjusted EBITDA and revenue to determine annual cash incentive awards and performance-based equity awards because they are important measures of our performance and the performance of our management, they drive our success and growth and they are key criteria by which management plans and analyzes our business. In addition, the Company uses certain non-financial measures to determine annual cash incentive awards in order to incentivize and align achievement for certain key qualitative metrics. Therefore, the most important financial performance measures (and only financial measures used in current plans/awards) used by the Company to link compensation actually paid to the Company’s NEOs, for the most recently completed fiscal year, to the Company’s performance are as follows:
| ● | Adjusted EPS
| ● | Adjusted EBITDA
| ● | Revenue
Total Shareholder Return Amount |  |  | $ 119 | 234 | 248 | 183 | 151
Peer Group Total Shareholder Return Amount |  |  | $ 126 | $ 124 | $ 118 | $ 147 | $ 134
Company Selected Measure Amount | $ / shares |  |  | 3.32 | 3.51 | 3.19 | 2.7 | 2.81
PEO Name | Ms. Osteen | Mr. Hunter | Mr. Hunter | Mr. Hunter |  | Ms. Osteen | Ms. Osteen
Equity Awards Adjustments, Footnote |  |  |
| (b) | Reflects the value of equity calculated in accordance with the SEC methodology for determining CAP for each year shown. The equity component of CAP is further detailed in the table below. For performance-vesting restricted stock unit awards, fair value amounts have been computed consistent with the methodology used in the Company’s Consolidated Financial Statements as of December 31, 2020, 2021, 2022, 2023 and 2024, respectively.
Equity Component of CAP: Christopher H. Hunter
Year |  |  | Fair Value of Current Year Equity Awards at Year-End |  |  | Change in Value of Prior Years’ Awards Unvested at Year-End |  |  | Change in Value of Prior Years’ Awards That Vested in the Year |  |  | Equity Value Included in CAP |
2024 |  |  | $ | 2,975,019 |  |  | $ | (5,148,737 | ) |  |  | (57,192 | ) |  | $ | (2,230,911 | )
2023 |  |  |  | 6,050,233 |  |  |  | (321,521 | ) |  |  | (30,589 | ) |  |  | 5,698,123 |
2022 |  |  |  | 6,566,930 |  |  |  | – |  |  |  | – |  |  |  | 6,566,930 |
2021 |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
2020 |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
Debra K. Osteen
Year |  |  | Fair Value of Current Year Equity Awards at Year-End |  |  | Change in Value of Prior Years’ Awards Unvested at Year-End |  |  | Change in Value of Prior Years’ Awards That Vested in the Year |  |  | Equity Value Included in CAP |
2024 |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
2023 |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
2022 |  |  | $ | 9,972,986 |  |  | $ | 7,341,244 |  |  | $ | (1,772,108 | ) |  | $ | 15,542,122 |
2021 |  |  |  | 23,567,139 |  |  |  | 3,215,353 |  |  |  | 166,885 |  |  |  | 26,949,377 |
2020 |  |  |  | 13,014,224 |  |  |  | 533,148 |  |  |  | 1,759,927 |  |  |  | 15,307,298 |
Average Non-CEO NEOs
Year |  |  | Fair Value of Current Year Equity Awards at Year-End |  |  | Change in Value of Prior Years’ Awards Unvested at Year-End |  |  | Change in Value of Prior Years’ Awards That Vested in the Year |  |  | Fair Value of Forfeited Awards at Prior Year-End |  |  | Equity Value Included in CAP |
2024 |  |  | $ | 679,492 |  |  | $ | (1,278,180 | ) |  | $ | (19,593 | ) |  | $ | (459,873 | ) |  | $ | (1,078,154 | )
2023 |  |  |  | 2,182,972 |  |  |  | (89,974 | ) |  |  | (255,921 | ) |  |  | (1,543,681 | ) |  |  | 293,396 |
2022 |  |  |  | 5,228,345 |  |  |  | 3,399,089 |  |  |  | (130,155 | ) |  |  | – |  |  |  | 8,497,279 |
2021 |  |  |  | 5,891,861 |  |  |  | 1,147,507 |  |  |  | 138,972 |  |  |  | – |  |  |  | 7,178,340 |
2020 |  |  |  | 4,691,771 |  |  |  | 419,942 |  |  |  | (48,996 | ) |  |  | – |  |  |  | 5,062,717 |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest |  |  | $ 264,484,000 | $ (15,661,000) | $ 280,033,000 | $ 195,562,000 | $ (669,199,000)
Measure:: 1 |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Name |  |  | Adjusted EPS |  |  |  |
Non-GAAP Measure Description |  |  |
| (7) | Adjusted EPS is a non-GAAP financial measure and one of the core long-term metrics we use for purposes of evaluating performance for our compensation program, as further described in the section above entitled “COMPENSATION DISCUSSION AND ANALYSIS – Components of Executive Compensation – Annual Non-Equity Incentive Compensation.”
Measure:: 2 |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Name |  |  | Adjusted EBITDA |  |  |  |
Measure:: 3 |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Name |  |  | Revenue |  |  |  |
Christopher H. Hunter [Member] |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
PEO Total Compensation Amount |  |  | $ 7,089,167 | 7,404,606 | 6,415,224 |  |
PEO Actually Paid Compensation Amount |  |  | (241,669) | 8,352,752 | 8,482,132 |  |
Debra K. Osteen [Member] |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
PEO Total Compensation Amount |  |  | 0 | 0 | 2,620,043 | 9,853,107 | 5,131,395
PEO Actually Paid Compensation Amount |  |  | 0 | 0 | 17,102,308 | 29,812,731 | 17,648,915
PEO | Christopher H. Hunter [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (5,099,925) | (4,749,977) | (4,500,022) |  |
PEO | Christopher H. Hunter [Member] | Equity Awards Adjustments, Excluding Value Reported in Compensation Table |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (2,230,911) | 5,698,123 | 6,566,930 | 0 | 0
PEO | Christopher H. Hunter [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 2,975,019 | 6,050,233 | 6,566,930 | 0 | 0
PEO | Christopher H. Hunter [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (5,148,737) | (321,521) | 0 | 0 | 0
PEO | Christopher H. Hunter [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (57,192) | (30,589) | 0 | 0 | 0
PEO | Debra K. Osteen [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 0 | 0 | (1,059,857) | (6,989,753) | (2,789,779)
PEO | Debra K. Osteen [Member] | Equity Awards Adjustments, Excluding Value Reported in Compensation Table |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 0 | 0 | 15,542,122 | 26,949,377 | 15,307,298
PEO | Debra K. Osteen [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 0 | 0 | 9,972,986 | 23,567,139 | 13,014,224
PEO | Debra K. Osteen [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 0 | 0 | 7,341,244 | 3,215,353 | 533,148
PEO | Debra K. Osteen [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 0 | 0 | (1,772,108) | 166,885 | 1,759,927
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (1,179,647) | (2,503,492) | (1,720,243) | (1,963,594) | (1,116,717)
Non-PEO NEO | Equity Awards Adjustments, Excluding Value Reported in Compensation Table |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (1,078,154) | 293,396 | 8,497,279 | 7,178,340 | 5,062,717
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 679,492 | 2,182,972 | 5,228,345 | 5,891,861 | 4,691,771
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (1,278,180) | (89,974) | 3,399,089 | 1,147,507 | 419,942
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (19,593) | (255,921) | (130,155) | 138,972 | (48,996)
Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | $ (459,873) | $ (1,543,681) | $ 0 | $ 0 | $ 0

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToNonPeoNeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToPeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iii + Details
Name: | ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph ii + Details
Name: | ecd_CompActuallyPaidVsNetIncomeTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph i + Details
Name: | ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii -Sentence B -Clause 1 -Subclause ii + Details
Name: | ecd_EqtyAwrdsAdjFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_MeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_NamedExecutiveOfficersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_NonGaapMeasureDescriptionTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_NonPeoNeoAvgCompActuallyPaidAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_NonPeoNeoAvgTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupIssuersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupTotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_PeoActuallyPaidCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_PeoName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_PeoTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 6 + Details
Name: | ecd_TabularListTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnVsPeerGroupTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 205 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(16)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 19 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19 Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 235 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-05(b)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7 Reference 31: http://www.xbrl.org/2003/role/exampleRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 4J -Publisher FASB -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J Reference 32: http://www.xbrl.org/2003/role/exampleRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 4K -Publisher FASB -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A Reference 34: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2 Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A Reference 37: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A + Details
Name: | us-gaap_ProfitLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ecd_MeasureAxis=1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=3
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=achc_ChristopherHHunterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=achc_DebraKOsteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_PeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |